SCHEMBL13028720

SCHEMBL13028720

C=C(N)SCc1ccc(CC#N)c2cccnc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.38
L3MBTL1 Q9Y468 5/20 0.38
HTT P42858 3/20 0.38
NPC1 O15118 3/20 0.38
LMNA P02545 3/20 0.38
RAB9A P51151 2/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BRD4 O60885 4/20 0.38
ALOX12 P18054 3/20 0.35
PAX8 Q06710 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
MAOB P27338 1/20 0.33
BACE1 P56817 1/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
ALOX15 P16050 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11940575 0.87 SLC11A2 (0.45) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL13028711 0.82 HPGD (0.40) HTTLMNASMN1; SMN2ALDH1A1TP53
SCHEMBL11940562 0.82 HTT (0.46) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL11940523 0.75 KDM4E (0.42) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL5594570 0.75 KDM4E (0.68) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL11940522 0.72 KDM4E (0.42) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL10641796 0.69 MAOA (0.57) KDM4EL3MBTL1HTTNPC1LMNA
SCHEMBL11940581 0.68 HTT (0.42) KDM4EHTTLMNASMN1; SMN2TP53
SCHEMBL11940555 0.68 HTT (0.58) KDM4EHTTLMNASMN1; SMN2ALDH1A1
SCHEMBL11940572 0.68 SLC11A2 (0.43) KDM4EHTTLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338454-B2 Nitrile derivatives and their pharmaceutical use and compositions CELLCEUTIX CORPORATION (US) 2012-12-25 US disclosed
US-20100298374-A1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS CELLCEUTIX CORPORATION (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298374-A1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS NOS1, NOS2, NOS3 KDM4E 3359/4885L3MBTL1 4472/4885HTT 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.